Trent 2010.
Methods |
Setting: 5 clinical sites in 2 institutions ‐ a large academic medical centre (John Hopkins School of Medicine) and a community hospital (Saint Agnes Hospital), Baltimore, MD, US The 5 sites of recruitment included the paediatrics and adult emergency department at both centres and the combined general paediatrics and adolescent medicine clinic in the large academic centre Enrolment: trained research assistants screened patients with mild‐to‐moderate PID regarding inclusion and exclusion criteria to determine eligibility ‐ from 14 February 2006 to 25 July 2008 Follow‐up: index patients returned for a 72‐hour follow‐up after treatment, and a 2‐week post‐treatment, face‐to‐face interview with DIS |
|
Participants | 162 index patients with mild‐to‐moderate PID, were approached about recruitment, 131 were enrolled, data gathered from 126 participants were successfully transferred at enrolment and could be randomised Inclusion criteria
Exclusion criteria
|
|
Interventions | Care of patients in both arms included detailed discharge instructions, a full 14‐day course of medication and a written hand‐out to facilitate self care Patient referral with video (n = 61) Index patient watched a 6‐minute video that tells the story of PID as related by a universal patient created by the voices and images of 7 different female adolescents. The video portrays the patient's interface with health provider and the male partner's interface and allows the universal girl to acknowledge the barriers and benefits of PID self care while providing cues for action Simple patient referral (n = 65) Index patient received standardised discharge instructions based on the 2006 CDC STI treatment guidelines |
|
Outcomes |
Primary outcomes
Secondary outcomes
|
|
Notes | The study was approved by the John Hopkins School of Medicine Institutional Review Board and the Saint Agnes Hospital Institutional Review Board. Additional approval was obtained from the Maryland State Attorney General for recruitment of children who were wards of the state at the time of diagnosis To reach 80% power to detect a statistically significant difference for the 72‐hour follow‐up visit at the P value = 0.05 level an additional 240 study subjects would have been needed. The authors were contacted for exact numbers of partners notified and treated but these numbers were not available |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated randomisation |
Allocation concealment (selection bias) | Unclear risk | Envelopes containing the group assignment and pertinent information materials were opened by participants after informed consent to participate had been obtained from each of them |
Incomplete outcome data (attrition bias) All outcomes | High risk | Only 81/126 (62%) index patients had a 2‐week follow‐up interview where information on PN were collected |
Selective reporting (reporting bias) | Low risk | Outcomes in method section same as in results. No protocol available from 3 trial registries |
Other bias | Low risk | No other bias identified |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participant and personnel not blinded |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Blinding of DIS unclear. The DIS performed the follow‐up standardised interview and completed a form. The DIS was not involved with randomisation or initial interaction with participant. Face‐to‐face interview can introduce bias |